Malaysia: Lukman escapes death penalty, not prison
Muhammad Lukman Mohamad, a Malaysian engineer who manufactured’cannabis oil to treat cancer patients will finally escape the death penalty after Malaysia's Federal Court accepted his appeal on two counts.
However, Lukman was convicted under Section 9 of the Dangerous Drugs Act (DDA) and sentenced to 5 years' imprisonment.
«The prosecution has failed to determine the weight of the drugs and the conviction cannot stand,» said Tengku Maimun, Chief Justice of Malaysia.
In August 2018, the High Court had found Lukman guilty of three counts of trafficking in 3mL of cannabis extract, 1.422g of delta 9 tetrahydrocannabinol and 279.81g of cannabis, and sentenced him to death. Late 2019, the Court of Appeal confirmed the death penalty on the first two counts, but reduced the third to possession.
Lukman has only appealed to the Supreme Court against the trafficking conviction.
«The exhibits were irregularly presented to the High Court, as was done in the absence of the trial judge,» said declared Hisyam Teh Poh Teik, Lukman's lawyer. He also stated that Lukman should not have been charged under the law (DDA) as he had only sold them for medical purposes.
His lawyer said his client would be released from Maran prison after a prison official completed the administration of rotan, the local whip.
«If not for the whip, he should be released immediately because the seven-year prison sentence is over, with a third remission,» he told FMT after the proceedings.
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login